ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 19 of 59
JMBS 2020, 5(5): 164–169
Clinical Medicine

The Investigation of the Dependence between Hand Eczema Severity and Some Cytokine Profile Parameters, Vitamin D Level, and Glucocorticoid Receptor Gene Polymorphism

Methkal A. M., Kuts L. V.

Hand eczema is one of the most important chronic diseases in the dermatology. There are a lot of researches presenting the role of individual cytokines in eczema development. However, currently, the complex analysis of cytokines, hormones, and gene polymorphisms' impact on the development of hand eczema and its severity is absent. Therefore, the purpose of our work was to study the possible association between hand eczema severity and rs41423247 SNP, the blood level of IL-17A, IL-2, and 25(OH)2D3. Material and methods. The venous blood of 143 patients with hand eczema aged (42.2±11.1) years was used in the study. During the patients examination the data on age, sex, BMI kg/m2, BMI ≥25 kg/m2 (%), smoking, IgE (iu/ml), IL-17A (pg/ml), IL-2 (pg/ml), and 25(OH)2D3 (ng/ml) were obtained. The HECSI index (Hand Eczema Severity Index) was also assessed in each subject. According to HECSI value all patients were divided into three subgroups: mild, moderate and severe eczema. BclI SNP (rs41423247) of the glucocorticoid receptor gene (NR3C1) was determined using PCR-RFLP method. The statistical analysis was performed using the program SPSS 22.0. Results and discussion. The obtained results showed that the number of overweight people was higher among patients with severe hand eczema compared to patients with mild to moderate disease (P = 0.052). It was also revealed that the concentration of IL-17A in the blood serum of patients with severe hand eczema was significantly higher than in patients with mild to moderate disease (P = 0.037). The distribution of BclI polymorphism genotypes (NR3C1 gene), the blood level of IgE, IL-2, and 25(OH)2D3 were statistically equal between patients with different degrees of hand eczema severity (P > 0.05). Conclusion. Thus, the IL-17A serum concentration and body mass index are related to hand eczema severity. However, the link between NR3C1 gene BclI polymorphism, the blood level of IgE, IL-2, 25(OH)2D3, and hand eczema severity was not detected

Keywords: BclI polymorphism, interleukin 17A, interleukin 2, vitamin D, hand eczema

Full text: PDF (Ukr) 286K

  1. Alikhan A, Lachapelle JM, Maibach HI. Textbook of Hand Eczema. Berlin-Heidelberg: Springer; 2014;455 p.
  2. Ghaderi R, Saadatjoo A. Quality of life in patients with hand eczema as health promotion: a case control study. Acta Dermatovenerol. Croat. 2014; 22(1): 32-39.
  3. Kouris A, Armyra K, Christodoulou C, Katoulis A, Potouridou I, Tsatovidou R, et al. Quality of life, anxiety, depression and obsessive-compulsive tendencies in patients with chronic hand eczema. Contact Dermatitis. 2015; 72(6): 367-370.
  4. Rozhivanova TA, Polesko IV, Shcherbakova MYu. Sovremennye predstavleniya o mikrobiocenoze kozhi i kishechnika u bol'nyh ekzemoj i metabolicheskim sindromom [Modern concepts of skin and intestinal microbiocenosis in patients with eczema and metabolic syndrome]. Klinicheskaya dermatologiya i venerologiya. 2015; 2: 11-16. [Russian]
  5. Molin S. Pathogenese des Handekzems. Der Hautarzt. 2019; 70: 755-759.
  6. Yoshizawa Y, Nomaguchi H, Izaki S, Kitamura K. Serum cytokine levels in atopic dermatitis. Clinical and Experimental Dermatology. 2002; 27: 225-229.
  7. Diepgen TL, Andersen KE, Chosidow O, Coenraads PJ.Guidelines for diagnosis, prevention and treatment of hand eczema. J Deutsche Dermatologische Gesellschaft (DDG). 2014; 1610: 3-79.
  8. Fleury I, Beaulieu P, Primeau M, Labuda D, Sinnett D, Krajinovic M. Characterization of the BclI Polymorphism in the Glucocorticoid Receptor Gene. Clinical Chemistry. 2003; 49(9): 1528-1532.
  9. Amatia N, Garg AV, Gaffen SL. IL-17 Signaling: The Yin and the Yang. IL-17 Signaling: The Yin and the Yang. Trends Immunollogy. 2017; 38(5): 310-322.
  10. Madhok V, Futamura M, Thomas KS, Barbarot S. What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 1. Epidemiology, mechanisms of disease and methodological issues. Clin Exp Dermatol. 2015; 40(3): 238-242.
  11. Tan Q, Yang H, Liu EM, Wang H. Establishing a Role for Interleukin-17 in Atopic Dermatitis-Related Skin Inflammation. J Cutan Med Surg. 2017; 21(4): 308-315.
  12. Simanski M, Harder J, Rademacher F. R Nase 7 in Cutaneous Defense. Int J Mol Sci. 2016; 17: Art 560.
  13. Bonefeld CM, Petersen TH, Bandier J, Agerbeck C, Linneberg A, Ross-Hansen K. et al. Epidermal filaggrin deficiency mediates increased systemic Thelper 17 immune response. Br J Dermatol. 2016.
  14. Mangusheva VYu. Vmіst іnterlejkinu-17a u hvorih na atopіchnij dermatit zalezhno vіd statі ta tyazhkostі perebіgu zahvoryuvannya [The content of interleukin-17 in patients with atopic dermatitis, depending on the sex and severity of the disease]. Art of Medicine. 2020; 1(13): 99-104. [Ukrainian]
  15. Denisova YaE. Sovremennye predstavleniya o molekulyarno-geneticheskih mekhanizmah vozniknoveniya istinnoj ekzemy [Modern views on the molecular genetic mechanisms of true eczema]. Nauchnye vedomosti Seriya Medicina. Farmaciya. 2013; 18(161): 5-11. [Russian]
  16. Bolotnaya LA, Kalashnikova VS. Rol' citokinov v patogeneze hronicheskoj ekzemy [The role of cytokines in the pathogenesis of chronic eczema]. Dermatovenerologiya. Kosmetologiya. Seksopatologiya. 2007; 4(10): 86-88. [Russian]
  17. Umar M, Sastry KS, Al Ali F, Al-Khulaifi M, Wang E, Chouchane AI. Vitamin D and the pathophysiology of inflammatory skin diseases. Skin Pharmacol Physiol. 2018; 31: 74-86.
  18. Bikle DD, Ng D, Oda Y, Hanley K, Feingold K, Xie Z. The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3. The Journal of Investigative Dermatology. 2002; 119: 1109-1113.
  19. Niebuhr M, Langnickel J, Draing C, Renz H, Kapp A, Werfel T. Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism. Allergy. 2008; 63(6): 728-734.
  20. Mallbris L, Carlin L, Wei T, Heilborn J, Nilsson MF, Granath F, et al. Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis. Experimental Dermatology. 2010; 19(5): 442-449.
  21. Baeke F, Korf H, Overbergh L, van Etten E, Verstuyf A, Gysemans C, et al. Human T lymphocytes a redirect targets of 1,25-dihydroxyvitamin D3 in the immune system. The Journal of Steroid Biochemistry and Molecular Biology. 2010; 121: 221-227.
  22. Mesquita KC, Igreja ACSM, Costa IMC. Atopic dermatitis and vitamin D: facts and controversies. An Bras Dermatol. 2013; 88(6): 945-53.
  23. Cheon BR, Shin JE, Kim YJ. et al. Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children. Korean J Pediatr. 2015; 58(3): 96-101.